TargetMol

TargetMol logo

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, specializing in chemical and biological research products and service to meet the research needs of global customers. With the help of fast and efficient global supply chain,professional and rigorous procurement process and timely dynamic news of products, you will save more time with less cost and lead in drug discovery and screening. We are equipped to meet an array of client’s requirements, varying from virtual screening to chemical structure optimization to the provision of commercial products. For further information on our products and services, take a look around our website.

Company Website

Product Listing

(+)-Mk-801 Maleate 10mM * 1mL (in DMSO)  | 99.00%

TargetMol

(+)-MK-801 is a potent noncompetitive antagonist of the NMDA receptor (RECEPTORS, N-METHYL-D-ASPARTATE) with Kd of 37.2 nM in rat brain membranes. The drug has been considered for the wide variety of neurodegenerative conditions or disorders in which NMDA receptors may play an important role.

More Information Supplier Page

(+)-Mk-801 Maleate 10mg  | 99.00%

TargetMol

(+)-MK-801 is a potent noncompetitive antagonist of the NMDA receptor (RECEPTORS, N-METHYL-D-ASPARTATE) with Kd of 37.2 nM in rat brain membranes. The drug has been considered for the wide variety of neurodegenerative conditions or disorders in which NMDA receptors may play an important role.

More Information Supplier Page

(+)-Mk-801 Maleate 25mg  | 99.00%

TargetMol

(+)-MK-801 is a potent noncompetitive antagonist of the NMDA receptor (RECEPTORS, N-METHYL-D-ASPARTATE) with Kd of 37.2 nM in rat brain membranes. The drug has been considered for the wide variety of neurodegenerative conditions or disorders in which NMDA receptors may play an important role.

More Information Supplier Page

(+)-Mk-801 Maleate 50mg  | 99.00%

TargetMol

(+)-MK-801 is a potent noncompetitive antagonist of the NMDA receptor (RECEPTORS, N-METHYL-D-ASPARTATE) with Kd of 37.2 nM in rat brain membranes. The drug has been considered for the wide variety of neurodegenerative conditions or disorders in which NMDA receptors may play an important role.

More Information Supplier Page

(+)-Pteryxin 1 mg  | 98%

TargetMol

(+)-Pteryxin has muscle-relaxant props. (+)-Pteryxin shows hepatoprotective and nitric oxide prodn. inhibitory activity.

More Information Supplier Page

(+)-Pteryxin 5 mg  | 98%

TargetMol

(+)-Pteryxin has muscle-relaxant props. (+)-Pteryxin shows hepatoprotective and nitric oxide prodn. inhibitory activity.

More Information Supplier Page

(+)-Shikonin 200 mg  | 98%

TargetMol

Shikonin is an TMEM16A chloride channel inhibitor (IC50: 6.5 μM). Shikonin is also a selective PKM2 inhibitor and can also suppress activation of the NF-κB pathway and inhibit TNF-α.

More Information Supplier Page

(+)-Shikonin 10mM * 1mL (in DMSO)  | 98.00%

TargetMol

Shikonin is an TMEM16A chloride channel inhibitor (IC50: 6.5 μM). Shikonin is also a selective PKM2 inhibitor and can also suppress activation of the NF-κB pathway and inhibit TNF-α.

More Information Supplier Page

(+)-Shikonin 200mg  | 98.00%

TargetMol

Shikonin is an TMEM16A chloride channel inhibitor (IC50: 6.5 μM). Shikonin is also a selective PKM2 inhibitor and can also suppress activation of the NF-κB pathway and inhibit TNF-α.

More Information Supplier Page

(+)-Shikonin 100 mg  | 98%

TargetMol

Shikonin is an TMEM16A chloride channel inhibitor (IC50: 6.5 μM). Shikonin is also a selective PKM2 inhibitor and can also suppress activation of the NF-κB pathway and inhibit TNF-α.

More Information Supplier Page

(+)-Shikonin 10 mg  | 98%

TargetMol

Shikonin is an TMEM16A chloride channel inhibitor (IC50: 6.5 μM). Shikonin is also a selective PKM2 inhibitor and can also suppress activation of the NF-κB pathway and inhibit TNF-α.

More Information Supplier Page

(+)-Shikonin 1 mL * 10 mM (in DMSO)  | 98%

TargetMol

Shikonin is an TMEM16A chloride channel inhibitor (IC50: 6.5 μM). Shikonin is also a selective PKM2 inhibitor and can also suppress activation of the NF-κB pathway and inhibit TNF-α.

More Information Supplier Page

(+)-Shikonin 25 mg  | 98%

TargetMol

Shikonin is an TMEM16A chloride channel inhibitor (IC50: 6.5 μM). Shikonin is also a selective PKM2 inhibitor and can also suppress activation of the NF-κB pathway and inhibit TNF-α.

More Information Supplier Page

(+)-Shikonin 50 mg  | 98%

TargetMol

Shikonin is an TMEM16A chloride channel inhibitor (IC50: 6.5 μM). Shikonin is also a selective PKM2 inhibitor and can also suppress activation of the NF-κB pathway and inhibit TNF-α.

More Information Supplier Page

(+)-Shikonin 10mg  | 98.00%

TargetMol

Shikonin is an TMEM16A chloride channel inhibitor (IC50: 6.5 μM). Shikonin is also a selective PKM2 inhibitor and can also suppress activation of the NF-κB pathway and inhibit TNF-α.

More Information Supplier Page

(+)-Shikonin 25mg  | 98.00%

TargetMol

Shikonin is an TMEM16A chloride channel inhibitor (IC50: 6.5 μM). Shikonin is also a selective PKM2 inhibitor and can also suppress activation of the NF-κB pathway and inhibit TNF-α.

More Information Supplier Page

(+)-Shikonin 50mg  | 98.00%

TargetMol

Shikonin is an TMEM16A chloride channel inhibitor (IC50: 6.5 μM). Shikonin is also a selective PKM2 inhibitor and can also suppress activation of the NF-κB pathway and inhibit TNF-α.

More Information Supplier Page

(+)-Shikonin 100mg  | 98.00%

TargetMol

Shikonin is an TMEM16A chloride channel inhibitor (IC50: 6.5 μM). Shikonin is also a selective PKM2 inhibitor and can also suppress activation of the NF-κB pathway and inhibit TNF-α.

More Information Supplier Page

(±) Clopidogrel hydrogen sulfate 100 mg  | 99%

TargetMol

Clopidogrel, an antiplatelet agent pharmacologically and structurally analogous to ticlopidine, is used to inhibit blood clots in various conditions such as cerebrovascular disease, peripheral vascular disease, and coronary artery disease.

More Information Supplier Page

(±) Clopidogrel hydrogen sulfate 1 mL * 10 mM (in DMSO)  | 99%

TargetMol

Clopidogrel, an antiplatelet agent pharmacologically and structurally analogous to ticlopidine, is used to inhibit blood clots in various conditions such as cerebrovascular disease, peripheral vascular disease, and coronary artery disease.

More Information Supplier Page

(±) Clopidogrel hydrogen sulfate 200 mg  | 99%

TargetMol

Clopidogrel, an antiplatelet agent pharmacologically and structurally analogous to ticlopidine, is used to inhibit blood clots in various conditions such as cerebrovascular disease, peripheral vascular disease, and coronary artery disease.

More Information Supplier Page

(±) Clopidogrel hydrogensulfate 50mg  | 99.04%

TargetMol

Clopidogrel, an antiplatelet agent pharmacologically and structurally analogous to ticlopidine, is used to inhibit blood clots in various conditions such as cerebrovascular disease, peripheral vascular disease, and coronary artery disease.

More Information Supplier Page

(±) Clopidogrel hydrogensulfate 100mg  | 99.04%

TargetMol

Clopidogrel, an antiplatelet agent pharmacologically and structurally analogous to ticlopidine, is used to inhibit blood clots in various conditions such as cerebrovascular disease, peripheral vascular disease, and coronary artery disease.

More Information Supplier Page

(±) Clopidogrel hydrogensulfate 500mg  | 99.04%

TargetMol

Clopidogrel, an antiplatelet agent pharmacologically and structurally analogous to ticlopidine, is used to inhibit blood clots in various conditions such as cerebrovascular disease, peripheral vascular disease, and coronary artery disease.

More Information Supplier Page

(±) Clopidogrel hydrogensulfate 10mM * 1mL (in DMSO)  | 99.04%

TargetMol

Clopidogrel, an antiplatelet agent pharmacologically and structurally analogous to ticlopidine, is used to inhibit blood clots in various conditions such as cerebrovascular disease, peripheral vascular disease, and coronary artery disease.

More Information Supplier Page